Saturday 17 October 2026
Export LNSR’s income statement to Excel — free account
LENSAR, Inc.
LNSR Healthcare Medical Devices
LENSAR, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $58.4 million, up 9.24% from fiscal 2024. In the quarter to June 2026, revenue grew 18.4%, EPS grew 291.7% and free cash flow grew 96.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
5.80
0.23
−3.81%
Follow LNSR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 3 | 5 | 5 |
| 3,251.75% | 324.05% | (517.96%) | (851.75%) | ||
| (77.94%) | (49.78%) | 42.24% | 49.58% | ||
ROIC |
0.00% | 0.00% | 0.00% | (379.01%) | |
Return on Tangible Assets |
(556.47%) | (511.49%) | 117.31% | 124.67% | |
Average Days of Receivables |
36.42 | 39.83 | 30.97 | 37.37 | |
Free Cash Flow per Share |
(0.99) | (1.25) | (1.00) | (0.60) | |
Free Cash Flow |
(11.88) | (14.91) | (12.16) | (7.40) | |
Capital Expenditures |
(0.09) | (0.08) | — | (0.11) | |
| Other line items | |||||
Cash ROIC |
131.42% | 185.47% | (50.09%) | (26.01%) | |
Accounts Receivable Turnover |
11.51 | 9.38 | 9.80 | 10.80 | |
Accounts Payable Turnover |
3.41 | 2.51 | 3.51 | 2.77 | |
Inventory Turnover |
1.79 | 1.90 | 1.63 | 1.41 | |
Average Days of Payables |
169.55 | 221.26 | 117.65 | 131.23 | |
Days of Inventory on Hand |
236.04 | 250.85 | 269.15 | 291.59 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.57% | 9.62% | 9.48% | 8.83% | |
Selling, General and Administrative Expense of Revenue |
70.44% | 77.28% | 63.32% | 51.47% | |
Share Based Compensation of Revenue |
4.96% | 5.38% | 5.51% | 4.58% | |
Operating CF/Net income |
0.23 | 0.43 | (0.41) | (0.21) | |
Depreciation/Fixed assets |
7.58 | 8.56 | 9.68 | 10.09 | |
Capex/Depreciation |
(0.02) | (0.02) | 0.00 | (0.02) | |
Revenue per Share |
4.91 | 4.89 | 4.75 | 4.90 | |
Operating CF per Share |
(0.98) | (1.24) | (1.00) | (0.59) | |
Capex per Share |
(0.01) | (0.01) | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates